Danaher Corp. (DHR): Price and Financial Metrics

Danaher Corp. (DHR): $243.60

-5.37 (-2.16%)

POWR Rating

Component Grades














  • Sentiment is the dimension where DHR ranks best; there it ranks ahead of 93.39% of US stocks.
  • The strongest trend for DHR is in Growth, which has been heading down over the past 179 days.
  • DHR ranks lowest in Momentum; there it ranks in the 19th percentile.

DHR Stock Summary

  • DHR has a higher market value than 98.96% of US stocks; more precisely, its current market capitalization is $211,629,909,042.
  • Danaher Corp's stock had its IPO on November 5, 1987, making it an older stock than 90.62% of US equities in our set.
  • With a price/sales ratio of 7.19, Danaher Corp has a higher such ratio than 80.11% of stocks in our set.
  • Stocks that are quantitatively similar to DHR, based on their financial statements, market capitalization, and price volatility, are ABT, TMO, MDT, CMCSA, and VZ.
  • Visit DHR's SEC page to see the company's official filings. To visit the company's web site, go to www.danaher.com.

DHR Valuation Summary

  • In comparison to the median Healthcare stock, DHR's price/sales ratio is 128.95% higher, now standing at 8.7.
  • DHR's price/sales ratio has moved up 6.7 over the prior 243 months.
  • DHR's price/earnings ratio has moved up 19.9 over the prior 243 months.

Below are key valuation metrics over time for DHR.

Stock Date P/S P/B P/E EV/EBIT
DHR 2021-08-31 8.7 5.4 42.5 34.7
DHR 2021-08-30 8.7 5.5 42.9 35.0
DHR 2021-08-27 8.5 5.3 41.8 34.2
DHR 2021-08-26 8.5 5.3 41.7 34.1
DHR 2021-08-25 8.5 5.3 41.9 34.2
DHR 2021-08-24 8.6 5.4 42.0 34.4

DHR Growth Metrics

    The year over year net cashflow from operations growth rate now stands at 78.5%.
  • Its 5 year revenue growth rate is now at -18.9%.
  • The 3 year revenue growth rate now stands at -6.28%.
Over the past 34 months, DHR's revenue has gone up $9,375,500,000.

The table below shows DHR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 29,453 8,358 6,269
2021-09-30 28,065.3 8,246.3 5,721.4
2021-06-30 26,719.5 7,935 5,446.8
2021-03-31 24,798.9 7,260 4,595.5
2020-12-31 22,284 6,208 3,510
2020-09-30 18,361 5,097.9 3,566.1

DHR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DHR has a Quality Grade of C, ranking ahead of 42.27% of graded US stocks.
  • DHR's asset turnover comes in at 0.36 -- ranking 56th of 75 Measuring and Control Equipment stocks.
  • IIVI, COHR, and INTT are the stocks whose asset turnover ratios are most correlated with DHR.

The table below shows DHR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.360 0.604 0.259
2021-07-02 0.353 0.592 0.255
2021-04-02 0.335 0.576 0.221
2020-12-31 0.308 0.560 0.168
2020-10-02 0.267 0.550 0.164
2020-07-03 0.266 0.553 0.164

DHR Price Target

For more insight on analysts targets of DHR, see our DHR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $334.69 Average Broker Recommendation 1.43 (Moderate Buy)

DHR Stock Price Chart Interactive Chart >

Price chart for DHR

DHR Price/Volume Stats

Current price $243.60 52-week high $333.96
Prev. close $248.97 52-week low $233.71
Day low $242.71 Volume 2,257,300
Day high $248.95 Avg. volume 2,996,364
50-day MA $270.71 Dividend yield 0.4%
200-day MA $296.16 Market Cap 177.12B

Danaher Corp. (DHR) Company Bio

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are "Life Sciences", "Diagnostics", and "Environmental & Applied Solutions". (Source:Wikipedia)

DHR Latest News Stream

Event/Time News Detail
Loading, please wait...

DHR Latest Social Stream

Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Danaher raises dividend by 19% to $0.25

Danaher Corporation (NYSE:DHR) declares $0.25/share quarterly dividend, 19.0% increase from prior dividend of $0.21.Forward yield 0.38%Payable April 29; for shareholders of record March 25;

Seeking Alpha | February 23, 2022

Danaher Announces Quarterly Dividends

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.25 per share of its common stock, payable on April 29, 2022 to holders of record on March 25, 2022. In addition, the Board of Directors has approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on April 15, 2022 to holders of record on March 31, 2022. The Board of Directors has also approved a quart

Yahoo | February 23, 2022

Global Laboratory Consumables Market Report, Featuring Profiles of Key Players Including Agilent, Beckman Coulter, Bio-Rad, PerkinElmer, Roche and Shimadzu

DUBLIN , Feb. 18, 2022 /PRNewswire/ -- The "Global Laboratory Consumables Market 2021" report has been added to ResearchAndMarkets.com''s offering. The Global Laboratory Consumables Market report is designed for general management, product managers and marketing executives in the laboratory consumables industry. For them, it provides up-to-date market data about those technologies in their areas of interest. and related markets. Information on specific segments or the whole industry can be used to evaluate markets, the competitive landscape, or identify opportunities and acquisition targets. A strategy for the consumables market must involve geographic market composition, market growth rate, and new competitors. This report saves time by providing comprehensive data in an easily readabl...

Benzinga | February 18, 2022

Hologic's Underperformance Makes This A Name Worth Further Consideration

Despite some impressive recent quarters, Hologic (HOLX) shares have underperformed since my last update on this diversified diagnostics and women’s health company. Hologic has benefited from an unexpectedly strong “tail” to COVID-19 testing revenue, but underlying performance has been solid as well, and the company is now in a much...

Stephen Simpson on Seeking Alpha | February 17, 2022

Here''s How Much You Would Have Made Owning Danaher Stock In The Last 10 Years

Danaher (NYSE: DHR ) has outperformed the market over the past 10 years by 8.65% on an annualized basis. Buying $1,000 In DHR: 10 years ago, an investor could have purchased 24.79 shares of Danaher at the time with $1,000. This investment in DHR would have produced an average … Full story available on Benzinga.com

Benzinga | February 14, 2022

Read More 'DHR' Stories Here

DHR Price Returns

1-mo -10.80%
3-mo -8.66%
6-mo -22.33%
1-year -2.00%
3-year 89.10%
5-year 203.79%
YTD -25.89%
2021 48.57%
2020 45.34%
2019 49.55%
2018 11.80%
2017 20.01%

DHR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7999 seconds.